In The News Archives - Worldwide Clinical Trials https://www.worldwide.com/newsroom-category/in-the-news/ Wed, 07 Feb 2024 13:31:17 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://www.worldwide.com/wp-content/uploads/2023/04/cropped-favicon-32x32.png In The News Archives - Worldwide Clinical Trials https://www.worldwide.com/newsroom-category/in-the-news/ 32 32 Flexibility in crisis: Disaster preparedness in clinical trials https://www.worldwide.com/newsroom/flexibility-in-crisis-disaster-preparedness-in-clinical-trials/ Sun, 19 Nov 2023 18:56:18 +0000 https://www.worldwide.com/?post_type=in_the_news&p=98023 The US Food and Drug Administration (FDA) released guidance in September 2023 on how sponsors should conduct trials during turbulent times, following questions about how trials should be handled during the COVID-19 pandemic. Read along here as our Chief Operating Officer Dave Bowser discusses what this guidance means for CROs and sponsors.

The post Flexibility in crisis: Disaster preparedness in clinical trials appeared first on Worldwide Clinical Trials.

]]> The US Food and Drug Administration (FDA) released guidance in September 2023 on how sponsors should conduct trials during turbulent times, following questions about how trials should be handled during the COVID-19 pandemic. Read along here as our Chief Operating Officer Dave Bowser discusses what this guidance means for CROs and sponsors.

The post Flexibility in crisis: Disaster preparedness in clinical trials appeared first on Worldwide Clinical Trials.

]]> Interview: Rare and orphan diseases and personalized drug development and treatment https://www.worldwide.com/newsroom/rare-and-orphan-diseases-and-personalized-drug-development-and-treatment/ Sun, 19 Nov 2023 18:46:20 +0000 https://www.worldwide.com/?post_type=in_the_news&p=98021 Our CEO Peter Benton and Chief Medical Officer Dr. Michael Murphy discuss personalized medicine and rare and orphan diseases with OutsourcingPharma. Click here to read their conversation.

The post Interview: Rare and orphan diseases and personalized drug development and treatment appeared first on Worldwide Clinical Trials.

]]> Our CEO Peter Benton and Chief Medical Officer Dr. Michael Murphy discuss personalized medicine and rare and orphan diseases with OutsourcingPharma. Click here to read their conversation.

The post Interview: Rare and orphan diseases and personalized drug development and treatment appeared first on Worldwide Clinical Trials.

]]> Podcast with Joy Clark: Creating a Culture of Belonging https://www.worldwide.com/newsroom/creating-a-culture-of-belonging-podcast-joy-clark/ Sun, 19 Nov 2023 18:23:22 +0000 https://www.worldwide.com/?post_type=in_the_news&p=98018 Listen in here as our Chief People Officer Joy Clark shares about Worldwide’s culture of belonging on the Huxley Morton podcast.

The post Podcast with Joy Clark: Creating a Culture of Belonging appeared first on Worldwide Clinical Trials.

]]> Listen in here as our Chief People Officer Joy Clark shares about Worldwide’s culture of belonging on the Huxley Morton podcast.

The post Podcast with Joy Clark: Creating a Culture of Belonging appeared first on Worldwide Clinical Trials.

]]> Understanding the new EU Clinical Trial Regulation: seven things sponsors should know https://www.worldwide.com/newsroom/understanding-the-new-eu-clinical-trial-regulations/ Wed, 20 Sep 2023 15:16:13 +0000 https://www.worldwide.com/?post_type=in_the_news&p=96676 In this article, originally published in January 2022, Sarah Bly and Aman Khera of Worldwide Clinical Trials, break down the seven key differences between the EU Clinical Trial Directive and new EU Clinical Trial Regulation, discussing when and how sponsors should begin submitting their trials through the new CTIS portal system.

The post Understanding the new EU Clinical Trial Regulation: seven things sponsors should know appeared first on Worldwide Clinical Trials.

]]> In this article, originally published in January 2022, Sarah Bly and Aman Khera of Worldwide Clinical Trials, break down the seven key differences between the EU Clinical Trial Directive and new EU Clinical Trial Regulation, discussing when and how sponsors should begin submitting their trials through the new CTIS portal system.

The post Understanding the new EU Clinical Trial Regulation: seven things sponsors should know appeared first on Worldwide Clinical Trials.

]]> Why and How to Infuse Methodological Rigor into Psychedelic Clinical Trials https://www.worldwide.com/newsroom/why-and-how-to-infuse-methodological-rigor-into-psychedelic-clinical-trials/ Wed, 20 Sep 2023 15:12:53 +0000 https://www.worldwide.com/?post_type=in_the_news&p=96675 An article written by Christine Moore, PhD, Vice President, Neuroscience, Scientific Solutions at Worldwide Clinical Trials.

The post Why and How to Infuse Methodological Rigor into Psychedelic Clinical Trials appeared first on Worldwide Clinical Trials.

]]> An article written by Christine Moore, PhD, Vice President, Neuroscience, Scientific Solutions at Worldwide Clinical Trials.

The post Why and How to Infuse Methodological Rigor into Psychedelic Clinical Trials appeared first on Worldwide Clinical Trials.

]]> Drug Development Agility with Safety First https://www.worldwide.com/newsroom/drug-development-agility-with-safety-first/ Wed, 20 Sep 2023 15:07:45 +0000 https://www.worldwide.com/?post_type=in_the_news&p=96674 In this podcast, Peter Benton, President and CEO for Worldwide Clinical Trials, speaks about his unconventional entrance into the industry, advice for clin-ops professionals, and much more.

The post Drug Development Agility with Safety First appeared first on Worldwide Clinical Trials.

]]> In this podcast, Peter Benton, President and CEO for Worldwide Clinical Trials, speaks about his unconventional entrance into the industry, advice for clin-ops professionals, and much more.

The post Drug Development Agility with Safety First appeared first on Worldwide Clinical Trials.

]]> Evolving Tools and Perspectives for the Development of Cell and Gene Therapies https://www.worldwide.com/newsroom/tools-and-perspectives-development-of-cell-and-gene-therapies/ Wed, 20 Sep 2023 14:59:31 +0000 https://www.worldwide.com/?post_type=in_the_news&p=96673 An article written by Amy Raymond, PHD, PMP, Executive Director Therapeutic Strategy Lead, Cellular and Genetic Medicines, Worldwide Clinical Trials.

The post Evolving Tools and Perspectives for the Development of Cell and Gene Therapies appeared first on Worldwide Clinical Trials.

]]> An article written by Amy Raymond, PHD, PMP, Executive Director Therapeutic Strategy Lead, Cellular and Genetic Medicines, Worldwide Clinical Trials.

The post Evolving Tools and Perspectives for the Development of Cell and Gene Therapies appeared first on Worldwide Clinical Trials.

]]> A leading CRO’s chief exec on why a ‘brave new world’ of clinical research is here https://www.worldwide.com/newsroom/brave-new-world-of-clinical-research-is-here/ Wed, 20 Sep 2023 14:49:46 +0000 https://www.worldwide.com/?post_type=in_the_news&p=96671 A Q&A with Peter Benton, President and CEO of Worldwide Clinical Trials. Peter explains how the rise of the mid-sized pharma company has changed drug R&D.

The post A leading CRO’s chief exec on why a ‘brave new world’ of clinical research is here appeared first on Worldwide Clinical Trials.

]]> A Q&A with Peter Benton, President and CEO of Worldwide Clinical Trials. Peter explains how the rise of the mid-sized pharma company has changed drug R&D.

The post A leading CRO’s chief exec on why a ‘brave new world’ of clinical research is here appeared first on Worldwide Clinical Trials.

]]> Trust: The Key to Operational Success in Post-COVID-19 Oncology Trials https://www.worldwide.com/newsroom/key-to-operational-success-in-post-covid19-oncology-trials/ Tue, 19 Sep 2023 13:16:41 +0000 https://www.worldwide.com/?post_type=in_the_news&p=96634 Trust is key in any clinical trial, especially post COVID-19. How can this trust be developed, and why is it integral to ensuring the success of the trial. An article written by Clare Wallis, President, Oncology Business Unit, Worldwide Clinical Trials, and Worldwide customer Teleen Norman, Senior Vice President, Clinical Operations, Xilio Therapeutics. Read more!

The post Trust: The Key to Operational Success in Post-COVID-19 Oncology Trials appeared first on Worldwide Clinical Trials.

]]> Trust is key in any clinical trial, especially post COVID-19. How can this trust be developed, and why is it integral to ensuring the success of the trial.

An article written by Clare Wallis, President, Oncology Business Unit, Worldwide Clinical Trials, and Worldwide customer Teleen Norman, Senior Vice President, Clinical Operations, Xilio Therapeutics.

Read more!

The post Trust: The Key to Operational Success in Post-COVID-19 Oncology Trials appeared first on Worldwide Clinical Trials.

]]>